Patient, Physician, and Health-System Factors Influencing the Quality of Antidepressant and Sedative Prescribing for Older, Community-Dwelling Adults.

Related Articles

Patient, Physician, and Health-System Factors Influencing the Quality of Antidepressant and Sedative Prescribing for Older, Community-Dwelling Adults.

Health Serv Res. 2016 Dec 26;:

Authors: Extavour RM, Perri M

Abstract
OBJECTIVE: To identify determinants of potentially inappropriate (PI) antidepressant and anxiolytic/sedative prescribing for older, community-dwelling adults.
DATA SOURCES/STUDY SETTING: Office visits from the 2010 National Ambulatory Medical Care Survey.
STUDY DESIGN: A cross-sectional study measuring associations between various patient and physician factors and prescribing of PI antidepressants, and PI sedatives among elderly, using Beers 2012/2015 criteria, a clinical decision model, and multivariate logistic regressions.
DATA COLLECTION: Visits by older adults (?65 years) involving medications were extracted to identify visits with antidepressants and sedatives.
PRINCIPAL FINDINGS: Black race, asthma, depression, osteoporosis, payment type, consultation time, and computer systems with prescribing support were associated with reduced odds of PI antidepressant prescribing among users. Income, chronic renal failure, diabetes, and obesity were associated with reduced odds of PI sedative prescribing. Female sex, white race, depression, increasing number of medications, and physician specialty were associated with increased odds of PI sedative prescribing.
CONCLUSIONS: Various patient and health-system factors influence the quality of antidepressant and sedative prescribing for older community-dwelling adults. Longer consultations and the use of computer systems with prescribing support may minimize potentially inappropriate antidepressant prescribing. As medication numbers increase, exposure to PI sedatives is more likely, requiring medication review and monitoring.

PMID: 28024315 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

FDA experts endorse Teva’s asthma drug, but reject use in key patient group – FierceBiotech


Fox News

FDA experts endorse Teva's asthma drug, but reject use in key patient group
FierceBiotech
An FDA advisory panel has handed Teva ($TEVA) a ringing endorsement for its IL-5 asthma drug reslizumab, offering a unanimous recommendation for marketing approval. That recommendation should quickly put it in direct rivalry with GlaxoSmithKline …
FDA advisers recommend approval of Teva asthma drug in adultsFox News
US FDA advisers recommend approval of Teva asthma drug for adultsReuters
FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic ReslizumabBusiness Wire (press release)

all 110 news articles »

View full post on asthma – Google News

Asthma expert Sebastian Johnston charges patient £6.5k for a 16 MINUTE … – Daily Mail


Daily Mail

Asthma expert Sebastian Johnston charges patient £6.5k for a 16 MINUTE
Daily Mail
A world-renowned British asthma expert charged a stunned patient almost £6,500 for a medical consultation lasting just 16 minutes, a tribunal has heard. Professor Sebastian Johnston, 56, filed an invoice for his advice, claiming the £6,500 cost
World-renowned asthma expert 'charged £6500 for 16-minute consultation'Mirror.co.uk
Top asthma doctor 'charged £6500 for 16 minute appointment he claimed was two Express.co.uk
Asthma expert hauled in front of tribunal after charging patient '£6500 for 16 The Sun

all 5 news articles »

View full post on asthma – Google News

World-renowned asthma expert stuns patient by ‘trying to charge him almost … – Daily Mail


Daily Mail

World-renowned asthma expert stuns patient by 'trying to charge him almost
Daily Mail
A world-renowned British asthma expert charged a stunned patient almost £6,500 for a medical consultation lasting just 16 minutes, a tribunal has heard. Professor Sebastian Johnston, 56, filed an invoice for his advice, claiming the £6,500 cost
Asthma expert hauled in front of tribunal after charging patient '£6500 for 16 The Sun

all 2 news articles »

View full post on asthma – Google News